2008, Número 6
<< Anterior Siguiente >>
Bol Med Hosp Infant Mex 2008; 65 (6)
Genética de la obesidad
Tejero ME
Idioma: Español
Referencias bibliográficas: 48
Paginas: 441-450
Archivo PDF: 139.52 Kb.
RESUMEN
La obesidad es la acumulación excesiva de tejido adiposo, consecuencia del desequilibrio energético. Los cambios en la disponibilidad y características de los alimentos y en la actividad física en las últimas décadas han dado lugar a que la ingestión de energía exceda al gasto. Esta tendencia se observa en todos los grupos de edad y en numerosos países. La respuesta a estos cambios ambientales que afectan a la dieta y actividad física es variada, y ciertos individuos y poblaciones parecen tener mayor predisposición al desarrollo de la obesidad y de sus comorbilidades. En la obesidad, en etapas tempranas de la vida, es importante diferenciar la obesidad ocasionada por anormalidades genéticas de aquellas formas comunes. Numerosas alteraciones genéticas se caracterizan por la obesidad. En algunos casos mutaciones en un solo gen, pueden tener un efecto importante sobre el índice de masa corporal (IMC). Este manuscrito presenta los aspectos genéticos de formas poco frecuentes y comunes de obesidad, con especial interés en la población infantil. También presenta diferentes abordajes metodológicos empleados en investigaciones sobre la genética de la obesidad y la variación en el IMC, incluyendo estudios de asociación de genes candidatos, barrido del genoma, asociación del genoma y estudios de perfil transcripcional. Actualmente, la obesidad se considera una enfermedad compleja con bagaje poligénico. Algunos alelos han sido asociados a la obesidad común y el IMC; sin embargo, los efectos observados son modestos y se requieren replicaciones en diferentes poblaciones para confirmar el efecto de estas variantes y establecer los mecanismos que explican su contribución a la obesidad.
REFERENCIAS (EN ESTE ARTÍCULO)
Ogden CL, Carroll DM, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295: 1549-55.
Olaiz G, Rivera J, Rojas R, Villalpando S, Hernández M. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006.
Butte NF, Christiansen E, Sørensen TI, editores. Energy imbalance underlying the development of childhood obesity. 2007; 15: 3056-66.
Perichart-Perera O, Balas-Nakash M, Schiffmann-Selechnik E, Barbato-Dosal A, Vadillo-Ortega F. Obesity increases metabolic syndrome risk factors in school-age children from urban school in Mexico City. JADA. Revista. 2007; 107: 81-91.
International obesity task http://www.revolutionhealth.com/conditions/obesity/obesity-epidemic force.
Butte NF, Comuzzie AG, Cole SA, Mehta NR, Cai G, Tejero M, et al. Quantitative genetic analysis of the metabolic syndrome in Hispanic children. Pediatr Res. 2005; 58: 1243-8.
Farooqi IS. Genetic and hereditary aspects of childhood obesity. Best Pract Res Clin Endocrinol Metab. 2005; 19: 635-43.
Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science. 1998; 280: 1371-4.
Cummings DE, Schwartz MW. Genetic and pathophysiology of human obesity. Ann Rev Med. 2003; 54: 453-71.
Loos RJF, Bouchard C. Obesity -is it a genetic disorder? J Intern Med. 2003; 254: 401-25.
Bouchard C, Tremblay A, Despres JP. The response to long-term overfeeding in identical twins. N Engl J Med. 1990; 322: 1477-82.
Comuzzie AG, Williams JT, Martin L, Blangero J. Searching for genes underlying normal variation in human adiposity. J Mol Med. 2001; 79: 57-70.
Bastarrachea R, Kent JW, Williams JT, Cai G, Cole SA, Comuzzie AG. The genetic contribution to obesity. En: Bray GA, Ryan DH, editores. Overweight and the metabolic syndrome: from bench to bedside: Springer; 2006.
Farooqi IS. Insights from the genetics of severe childhood obesity. Horm Res. 2007; 68: 5-7.
Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab. 2004; 15: 12-20.
Weinstein LS, Chen M, Liu J. Gs (alpha) mutations and imprinting defects in human disease. Ann N Y Acad Sci. 2002; 968: 173-97.
Couvert P, Bienvenu T, Aquaviva C. MECP2 is highly mutated in X-linked mental retardation. Hum Mol Genet. 2001; 10: 941-6.
Kleesftra T, Yntema HG, Oudakker AR. De novo MECP2 fram shift mutation in a boy with moderate mental retardation, obesity and gyneacomastia. Clin Genet. 2002; 61: 359-62.
Katsanis N. The oligogenic properties of Bardet-Biedl syndrome. Hum Mol Genet. 2004; 13: R65-R71.
Farooqi IS, O’Rahilly S. Genetics of obesity in humans. Endocr Rev. 2006; 27: 710-8.
Farooqi IS, Keogh JM, Yeo GS. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003; 348: 1085-95.
Rached M, Buronfosse A, Begeot M, Penhoat A. Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor gene (MC3R) mutation associated with obesity. Biochim Biophys Acta. 2004; 1689: 229-34.
Montague CT, Farooqi IS, Whitehead JP. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997; 387: 903-8.
Clement K, Vaisse C, Lahlou N. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998; 392: 398-401.
Ma L, Tataranni PA, Bogardus C, Baier LJ. Melanocortin 4 receptor gene variation is associated with severe obesity in Pima Indians. Diabetes. 2004; 53: 2696-9.
Perusse L, Rankinen T, Zuberi A. The human obesity gene map: the 2004 update. Obes Res. 2005; 13: 381-490.
Bastarrachea RA, López-Alvarenga JC, Kent JW. Transcriptoma en mexicanos: Análisis del perfil de expresión genética de gran escala en muestras simultáneas de tejido muscular, adiposo y linfocitos. Gac Med Mex. 2008 (En prensa).
Dahlman I, Linder K, Arvidsson NE, Ander E. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr. 2005; 81: 1275-85.
De Mello V, Kolehmainen M, Schwab U. Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome. Metabolism. 2008; 57: 192-9.
Mitchell B, Blangero J, Comuzze AG. A paired sibling analysis of the beta-3 adrenergic receptor and obesity in Mexican-Americans. J Clin Invest. 1998; 47: 617-21.
Widen E, Lehto M, Kannine T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the beta 3-adrenergic -receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med. 1995; 333: 348-51.
Xinli Q, Xiaomei T, Meihua P, Song L. Association of a mutation in the beta 3-adrenergic-receptor gene with obesity in response to dietary intervention in Chinese children. Acta Pediatr. 2001; 90: 1233-7.
Cole SA, Mitchell BD, Hsueh WC. The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican-Americans. Int J Obes Relat Metab Dis. 2000; 24: 522-4.
Deeb SS, Fajas L, Menoto M. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998; 20: 284-7.
Benzinou M, Chevre JC, Warad KJ. Endocanabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations. Hum Mol Genet. 2008; 17: 1916-21.
Comuzzie AG, Almasy L, Cole SA. Linkage exclusion analysis of the chromosome 11 region containing UCP2 and UCP3 with obesity-related phenotypes in Mexican-Americans. Int J Obes Metab Disord. 2000; 24: 1065-8.
Sutton BS, Langefeld CD, Williams AH. Association of proopiomelanocortin gene polymorphisms with obesity in the IRAS family study. Obes Res. 2005; 13: 1491-8.
Guizar-Mendoza JM, Amador-Licona N, Flores-Martínez SE, López-Cardona MG, Ahuatzin-Tremary R, Sánchez-Corona J. Association analysis of the Gln223Arg polymorphism in the human leptin receptor gene, and traits related to obesity in Mexican adolescents. J Hum Hypertens. 2005; 19: 341-6.
Canizales-Quinteros S, Aguilar-Salinas CA, Ortiz-López MG. Association of PPARG2 Pro12Ala variant with larger body mass index in Mestizo and Amerindian populations of Mexico. Hum Biol. 2007; 79: 111-9.
Meyre D, Lecour C, Delplanque J, Francke S, Vatin V, Durand E. A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-q23.2. Diabetes. 2004; 53: 803-11.
Ghoussaini M, Vatin V, Lecoeur C. Genetic study of the melanin-concentrating hormone receptor 2 in childhood and adulthood severe obesity. J Clin Endocrinol Metabol. 2007; 92: 4403-9.
Cai G, Cole SA, Voruganti VS, Butte NF, Comuzzie AG. Genome-wide scan revealed genetic loci for energy metabolism in Hispanic children and adolescents. Int J Obes. 2008; 32: 579-85.
Comuzzie AG, Tejero ME, Funahashi T. The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes. Hum Biol. 2007; 79: 191-200.
Herbert A, Gerry NP, McQueen MB. A common genetic variant is associated with adult and childhood obesity. Science. 2006; 312: 279-83.
Frayling TM, Timpson NJ, Weedon MN. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007; 316: 889-94.
Gerken T, Girard YC, Tung CJ. The obesity-associated gene FTO encodes for a 2-oxoglutarate-dependent nucleic acid demethylase. Science. 2007; 328: 1469-72.
Jacobsson JA, Danielsson P, Svensson V. Major gender differences in association of FTO gene variant among severely obese children with obesity and obesity related phenotypes. BBRC. 2008; 368: 476-82.
Chambers JC, Elliott P, Zabaneh D. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008 (Advance on line pub).